N-(6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)-5-p-tolylpyrimidin-4-yl)-2-phenylethenesulfonamide

ID: ALA4573806

PubChem CID: 9829478

Max Phase: Preclinical

Molecular Formula: C25H22BrN5O4S

Molecular Weight: 568.45

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2c(NS(=O)(=O)/C=C/c3ccccc3)ncnc2OCCOc2ncc(Br)cn2)cc1

Standard InChI:  InChI=1S/C25H22BrN5O4S/c1-18-7-9-20(10-8-18)22-23(31-36(32,33)14-11-19-5-3-2-4-6-19)29-17-30-24(22)34-12-13-35-25-27-15-21(26)16-28-25/h2-11,14-17H,12-13H2,1H3,(H,29,30,31)/b14-11+

Standard InChI Key:  RPBOIJRVAJKCSF-SDNWHVSQSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
    3.9828   -1.0236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3955   -1.7334    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.8039   -1.0211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4023   -3.3678    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4012   -4.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1092   -4.5963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8189   -4.1868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8161   -3.3642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1074   -2.9589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5192   -2.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2287   -3.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9344   -2.9513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9318   -2.1332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2176   -1.7275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5148   -2.1404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1050   -2.1417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6896   -2.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9807   -1.7395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2742   -2.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5692   -1.7427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8632   -2.1527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8652   -2.9708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5791   -3.3771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2822   -2.9647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5272   -4.5943    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5285   -5.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2369   -5.8190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2382   -6.6362    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9465   -7.0437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9434   -7.8593    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6510   -8.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3590   -7.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3551   -7.0356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6470   -6.6318    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0679   -8.2635    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    8.6374   -1.7210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 10  1  0
  9 16  1  0
 16  2  1  0
  2 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
  7 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 32 35  1  0
 13 36  1  0
M  END

Associated Targets(Human)

EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRB Tclin Endothelin receptor ET-B (1928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 568.45Molecular Weight (Monoisotopic): 567.0576AlogP: 4.87#Rotatable Bonds: 10
Polar Surface Area: 116.19Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.07CX Basic pKa: 3.39CX LogP: 5.12CX LogD: 4.72
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.27Np Likeness Score: -1.08

References

1. Boss C, Bolli MH, Gatfield J..  (2016)  From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective.,  26  (15): [PMID:27321813] [10.1016/j.bmcl.2016.06.014]

Source